Table 7 Relationship between production of scientific literature on Lassa fever and total production in some fields of infectious diseases in world 10 most productive countries in biomedical and health sciences
From: Bibliometric analysis of global Lassa fever research (1970–2017): a 47 – year study
Country | IPa Medicineb | IP Health Professionsa | IP Pharmacology, Toxicology and Pharmaceuticsa | IP Lassa Feverc | IP Tuberculosisb | IP AIDSb |
|---|---|---|---|---|---|---|
United States | 25.51 | 49.80 | 15.01 | 40.87 | 18.38 | 33.76 |
United Kingdom | 8.07 | 14.43 | 4.14 | 10.63 | 8.04 | 7.43 |
Germany | 6.10 | 1.36 | 3.17 | 8.72 | 3.78 | 3.81 |
China | 5.86 | 0.39 | 1.,37 | 0.82 | 3.25 | 3.17 |
Japan | 4.29 | 0.65 | 3.12 | 1.91 | 4.29 | 2.12 |
France | 3.84 | 0.66 | 1.71 | 4.00 | 4.50 | 3.72 |
Canada | 3.64 | 6.27 | 1.44 | 2.91 | 2.22 | 3.32 |
Italy | 3.08 | 0.74 | 1.95 | 1.09 | 2.84 | 2.93 |
Australia | 2.79 | 5.91 | 1.18 | 0.91 | 1.53 | 2.43 |
Spain | 2.78 | 0.65 | 1.34 | 0.64 | 2.87 | 2.10 |